BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hope in Focus - ECPv6.15.13//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://old.hopeinfocus.org
X-WR-CALDESC:Events for Hope in Focus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210216T150000
DTEND;TZID=America/New_York:20210216T160000
DTSTAMP:20260521T132802
CREATED:20210122T184235Z
LAST-MODIFIED:20210216T181255Z
UID:1372-1613487600-1613491200@old.hopeinfocus.org
SUMMARY:Let's Chat About: FDA Review of Rare Retinal Disease Treatments
DESCRIPTION:Sofia Sees Hope is proud to bring our web series “Let’s Chat About …” to the Leber congenital amaurosis and rare inherited retinal disease communities. We’ve developed the series with those living with LCA and IRDs in mind\, but we invite all members of our community\, including those in research\, industry\, and the regulatory communities to join any of the sessions\, as we look ahead to a common goal of advancing treatments for rare retinal disease. \n\nWiley Chambers\, MD\, Supervisory Medical Officer\, Office of New Drugs\, Center for Drug Evaluation and Research\, U.S. Food and Drug Administration (FDA)\n\n\nLet’s Chat About … What it takes to receive approval for retinal disease treatments from the FDA. \n\nWiley Chambers \n\n\nDr. Chambers joined the FDA in 1987\, as a primary reviewer for ophthalmic drug products and in 1990 became a Supervisory Medical Officer for Ophthalmologic Drug Products. In this capacity\, Dr. Chambers has supervisory responsibility for the clinical review of ophthalmologic drug products and ophthalmic therapeutic biologic products submitted to the Center for Drug Evaluation and Research.  He is currently a Clinical Professor of Ophthalmology and Adjunct Assistant Professor of Computer Medicine at The George Washington University. \nREGISTER
URL:https://old.hopeinfocus.org/event/fda-review-of-rare-retinal-disease-treatments/
CATEGORIES:Let's Chat About ...
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210127T130000
DTEND;TZID=UTC:20210127T140000
DTSTAMP:20260521T132802
CREATED:20210119T190952Z
LAST-MODIFIED:20210119T192501Z
UID:1366-1611752400-1611756000@old.hopeinfocus.org
SUMMARY:Webinar: Let's Chat About ... the Latest in LCA Therapy Research
DESCRIPTION:Sofia Sees Hope is proud to bring our web series “Let’s Chat About …” to the Leber congenital amaurosis and rare inherited retinal disease communities. We’ve developed the series with those living with LCA and IRDs in mind\, but we invite all members of our community\, including those in research\, industry\, and the regulatory communities to join any of the sessions\, as we look ahead to a common goal of advancing treatments for rare retinal disease. \n\nBen Shaberman\, Senior Director\, Scientific Outreach & Community Engagement\, Foundation Fighting Blindness\n\n\nLet’s Chat About … What’s in the therapy pipeline for Leber congenital amaurosis. \nBen Shaberman \nFor 16 years\, Ben has been reporting on retinal research for all of FFB’s electronic and print publications. In addition\, he presents the latest scientific advancements at local and national events for patients and families\, and conducts various training activities for staff and constituents. He enjoys working with constituents one-on-one to help them understand their retinal disease and the research underway that may benefit them. Ben also leads the company’s outreach to eye care professionals throughout the United States. \nREGISTER
URL:https://old.hopeinfocus.org/event/webinar-lets-chat-about-the-latest-in-lca-therapy-research/
CATEGORIES:Let's Chat About ...
ATTACH;FMTTYPE=image/jpeg:https://old.hopeinfocus.org/wp-content/uploads/2021/01/lets_chat_about_web_banner.jpg
END:VEVENT
END:VCALENDAR